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Minireview
Protein-protein interaction networks in the spinocerebellar ataxias
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Abstract
A large yeast two-hybrid study investigating whether the proteins mutated in different forms of
spinocerebellar ataxia have interacting protein partners in common suggests that some forms do
share common pathways, and will provide a valuable resource for future work on these diseases. 
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The spinocerebellar ataxias are a group of heritable human
neurodegenerative disorders that result in the loss of cere-
bellar Purkinje cells; patients have difficulties with balance
and coordination. There are a number of different forms, in
both humans and mouse models, with similar phenotypes
but with different genes mutated. Given the similar pheno-
types of these disorders, it would be of interest to know
whether the proteins known to be mutated in the different
forms interact with any of the same protein partners. In
work published recently, Zoghbi and colleagues [1] have now
addressed this question using the yeast two-hybrid protein-
protein interaction system.
Building resources
The yeast two-hybrid system allows the identification of
potential binary protein-protein interactions by exploiting
the characteristics of transcription factors that are composed
of separable DNA-binding domains and transcriptional
transactivation domains. Typically, in one vector - the ‘bait’ -
the potential protein target is fused to the DNA-binding
domain from a transcriptional activator such as yeast Gal4
or bacterial LexA. In a second vector, the transcriptional
activation domain of Gal4 or LexA is fused in-frame to a
library of complete or partial open reading frames or cDNAs,
called the ‘preys’. The preys represent the potential interac-
tion partners for the bait. When the bait interacts with a prey
in the yeast nucleus, the transactivation and DNA-binding
domains are brought together, reconstituting a functional
transcriptional activator. This event is assayed using
appropriate (and in some cases, multiple) reporter genes.
Automation, together with refinements in the yeast two-
hybrid methodology that have reduced the previously high
false-positive hit rates, make it possible to perform such
studies on a large scale, using libraries of thousands of baits
and preys [2]. This has led to detailed genome-wide studies
of potentially interacting proteins in model organisms -
delineating the protein ‘interactome’ - and the first studies of
the interactome in humans [3,4]. Along with such genome-
wide work, there have also been influential studies based on
a single target. For instance, Wanker and colleagues [5] have
focused on the interactors of huntingtin, the protein mutated
in Huntington’s disease.
The new work from Lim et al. [1] on the spinocerebellar
ataxias is an interesting variation on the theme of the tar-
geted interactome strategy. The authors took 23 proteins that
are mutated in dominant or recessive forms of spinocerebel-
lar ataxias in humans or mice, along with 31 other proteins
known to interact with some of these primary disease pro-
teins, and used yeast two-hybrid technology to place them
into a protein-protein interaction network. They identified
770 protein-protein interactions, many of these involving
more than one protein (Figure 1). This network was further
expanded using additional data found in the literature. 
This spinocerebellar ataxia interactome study [1] and related
projects provide data resources of great value to biologicalscientists. A large number of likely binary protein-protein
interactions are revealed, along with information on interac-
tors of interactors. In a general sense, this provides a power-
ful set of starting points for further studies leading to the
understanding of the biological functions of the various pro-
teins. The availability of large resources such as this study
gives us a powerful tool that I suspect will increasingly
change the way we approach problems in cell biology. 
Common pathways
From a disease perspective, the study by Lim et al. [1] sug-
gests that there may be common pathways shared by differ-
ent disease proteins. For instance, their screen revealed a
possible link between Purkinje cell atrophy associated
protein-1 (Puratrophin-1) and the protein (ataxin-1) mutated
in spinocerebellar ataxia type 1 through interactions with
Coilin-interacting protein. Recently, Puratrophin-1 was
implicated in a form of autosomal dominant spinocerebellar
ataxia linked to 16q22.1 [6]. In addition, some of the newly
identified partner proteins interact with more than one
ataxia protein. Indeed, the interaction network created using
the spinocerebellar ataxia proteins shows greater connectiv-
ity, shorter interaction path lengths linking different pro-
teins, and more proteins showing multiple interactions
compared with control networks created from a list of pro-
teins associated with a phenotypically diverse group of disor-
ders [1]. This reinforces the likelihood that similar biological
pathways are perturbed in certain spinocerebellar ataxias
caused by different mutated genes. If such pathways turn out
to be critical to neurodegeneration, this may point to
tractable therapeutic targets that are shared among a range
of diseases - an enticing prospect. A corollary to this is that
certain proteins in this network may be excellent functional
candidates for as-yet unidentified ataxia loci, if they map to
the appropriate genetic intervals. 
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Figure 1
An interaction network of proteins involved in spinocerebellar ataxias. The yeast two-hybrid interaction data of Lim et al. [1] reveal one large
interconnected network consisting of 752 protein-protein interactions between 36 ataxia-associated proteins and 541 prey proteins. Circles (nodes)
represent proteins, and any two proteins connected by a line have been shown to interact in the yeast two-hybrid (Y2H) screen. Blue circles depict
protein baits corresponding to the proteins known to be mutated in ataxias; red circles depict protein baits that are paralogs of ataxia-causing proteins
or known interactors with them. The yellow circles depict prey proteins tested in the yeast two-hybrid screen and come from two sources. Those
connected by a purple line to a node come from the human open reading frame library (the hORFeome), while those connected by a green line come
from a human brain cDNA library. All lines represent either first- or second-order interactions to ataxia-causing proteins. First-order interactions are
direct interactions, while second-order interactions occur via an intermediary protein. Reproduced with permission from Elsevier [1].
Y2H bait: ataxia-causing protein
Y2H bait: paralog to or interactor
with ataxia-causing protein
Y2H prey
Interaction from hORFeome
Interaction from cDNA libraryThe current study [1], when viewed in the context of previ-
ous genetic modifier screens in Drosophila models of spino-
cerebellar ataxia types 1 and 3, suggests that enhanced or
decreased function of some of the interacting proteins can
modulate the severity of spinocerebellar ataxia type 1 [7,8].
For instance, wild-type ataxin-2 and the Drosophila Couch
Potato protein have previously been shown to be modifiers
of mutant ataxin-1 toxicity in flies. Lim et al. [1] have now
confirmed the human orthologs of these modifiers as ataxin-1
interactors. As the previous genetic modifier screens were
not saturating, other interactors in the network may also be
considered as potential modifiers. 
Limitations
Such large datasets are not without caveats. About 80% of a
sample of the yeast two-hybrid hits in the spinocerebellar
ataxia study were confirmed using coaffinity purification, a
high success rate for this type of study [1]. Nevertheless, this
suggests that about 20% of untested yeast two-hybrid inter-
actions may be false positives. In addition to technical false
positives, one can also see biological false positives: for
instance, when two proteins genuinely interact in vitro or in
the yeast nucleus but are never found in the same cell com-
partment or the same cell type, and thus cannot interact in
vivo. The proportion of biological false positives may be low,
but it needs to be borne in mind. 
The large-scale mammalian protein-protein interaction net-
works reported to date are only partially complete [3,4]. The
prey libraries only partially cover the genome and some of
the baits may not have been efficient, either because they
were not functional or properly folded in yeast, or because
they could not interact with partners in the yeast nucleus, a
prerequisite for yeast two-hybrid screens. Thus, the cur-
rently available mammalian studies will probably serve as
starting frameworks for future, more comprehensive screens
using both yeast two-hybrid and complementary approaches
for identifying protein-protein interactions.
What are the challenges for the future? In general, there will
be major benefits if one can move towards datasets with
even fewer false-positive interactions and more real interac-
tions, some of which may need to be captured with alterna-
tive technologies such as affinity purification followed by
mass spectrometry. Studies based on the concept pioneered
by Lim et al. [1] are likely to investigate other diseases with
similar phenotypes but different gene mutations, and may
reveal novel shared pathways. For instance, Zoghbi and col-
leagues [1] suggest that such studies may be useful in dia-
betes, Parkinson’s disease and hypertension. 
One of the key issues is distilling functional sense out of
these large datasets. In the context of disease studies like
that on spinocerebellar ataxia [1] or the huntingtin interac-
tome [5], specific hypotheses can often be readily tested by
confirming interactions and then assessing whether they
modulate the functions of the wild-type or disease proteins.
Indeed, this has been demonstrated for one of the huntingtin
interactors, GIT1, a G-protein-coupled receptor kinase-inter-
acting protein, which enhances huntingtin aggregation by
recruiting it into membrane vesicles [5]. In this context, the
existing studies represent real gifts to researchers working
on these diseases. 
Ideally, we would like to be able to move from papers report-
ing large lists of interacting proteins of uncertain functional
significance to a situation where the interaction networks
form part of a representation of functional networks in cells.
I suspect that such data may evolve from the integration of
interactome data with gene-expression profiles and studies
of single and double knockouts in model organisms or mam-
malian cells. Along with such ‘wet-lab’ experiments comes
the need for user-friendly databases that allow efficient and
reliable interpretation of protein-protein interactors and
integrated datasets. In the meantime, the wealth of data in
the public domain resulting from these large scale studies is
a resource that is likely to fuel many exciting new studies on
the biological significance of specific binary interactions. 
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